IRGM stimulates autophagy when cells are starved of energy or contact bacterial components. How is it linked to Crohn’s disease? Read on to learn more.
IRGM (immunity-related GTPase family M protein) is a cog in the machinery of the immune system that regulates autophagy. Autophagy (from the Greek for self-eating) is the regulated process by which a cell breaks down dysfunctional or foreign components. The cell can then recycle useful chemical components for further purposes [R].
IRGM can be activated by three signals (that we know of): starvation (lack of energy), interferons (antiviral and antimicrobial response proteins), and contact with bacteria or bacterial products [R, R].
During a bacterial infection, some white blood cells ingest and break down the invaders using the process of autophagy. Researchers believe that IRGM is required for the cell to trigger autophagy in response to microbes [R, R, R].
Without IRGM, cells would be more susceptible to damage and bacterial infection. On the other hand, overexpression of IRGM can trigger cell death by damaging the mitochondria [R].
IRGM is activated by starvation, interferons, or contact with bacterial products. In turn, it triggers the process of autophagy.
Well-regulated autophagy is important for the maintenance of the intestinal lining, which forms the major barrier between bacteria in the gut and our bloodstreams. As such, IRGM is a major player in our gut health [R, R].
What is Crohn’s Disease?
IBD is a group of autoimmune diseases characterized by inflammation and sores in the gut lining, which can result in diarrhea, abdominal pain, fatigue, fever, rectal bleeding, nutritional deficiencies, and weight loss. The definition of IBD includes both ulcerative colitis and Crohn’s disease [R].
Crohn’s disease differs from ulcerative colitis in that it is centered higher in the digestive tract (typically in the small intestine, though it can occur anywhere between the mouth and anus) and may damage broader swaths of tissue [R, R].
IRGM & Crohn’s Disease
IRGM is relatively well-studied as a genetic risk factor for Crohn’s disease [R, R].
The level of expression of IRGM is highly variable from tissue to tissue, and there is some confusion about whether high or low IRGM may increase the risk of Crohn’s. On the one hand, autophagy plays an important role in maintaining the intestinal barrier and preventing bacterial infection; on the other, IRGM overexpression may cause cell death in the lining of the gut [R, R].
Genetic association studies can provide some clues about whether high or low gut IRGM could be harmful. In cell studies, risk alleles have been associated with both higher and lower IRGM expression, depending on the cell type. In human studies, however, risk alleles have been associated with increased IRGM in the gut tissues specifically [R].
A possible mechanism for IRGM and Crohn’s disease may be that very high IRGM triggers cell death in the intestinal lining. However, some researchers have also found evidence of IRGM deficiency in models of IBD [R, R].
IRGM mutations are linked with Crohn’s disease, but researchers disagree about whether very high or very low IRGM is more likely to cause IBD.
Interactions With Other Gut Inflammation Genes
IRGM is known to interact with and possibly regulate other genes that have been implicated in Crohn’s disease. The most conspicuous among these are TNF and NOD2 [R, R].
If you have detrimental mutations in IRGM, check out these other genes as well.
Multiple IRGM variants have been associated with increased rates of Crohn’s disease. These include:
- The ‘T’ allele of rs1000113 [R]
- The ‘G’ allele of rs7714584 [R]
- The ‘G’ allele of rs11747270 [R]
- The ‘C’ allele of rs13361189 [R]
- The ‘G’ allele of rs11741861 [R]
- The ‘T’ allele of rs10065172 [R]
In each of these cases, the rare allele is the one associated with disease. Little research has been done into how these alleles change the expression or activity of IRGM, though one study found significantly increased IRGM expression in the gut of Crohn’s disease patients with one copy of the risky ‘T’ allele at rs10065172 compared to those with no copies. However, the relationship between the ‘TT’ homozygous genotype and IRGM expression was less clear [R].
A more consistent finding has been that risk alleles in IRGM increase the expression of TNF-alpha, a strong proinflammatory cytokine which is dramatically increased in Crohn’s disease patients. Oddly, increased TNF expression has been linked with IRGM deficiency in some human cell studies, throwing another wrench in the research [R].
It is also possible that different IRGM risk alleles have different effects on expression, with some causing overexpression and some causing deficiency. Additional research is required.
At least six common IRGM variants have been significantly associated with Crohn’s disease. The precise mechanism of effect of these variants remains unclear.
Lifestyle
Improve Sleep
Sleep deprivation and chronic insomnia increase TNF-alpha and inflammation; meanwhile, autophagy is activated and does most of its work during sleep [R, R, R].
People with IBD are at increased risk of sleep disturbances due to discomfort, pain, and irregular bowel movements. Meanwhile, some researchers believe that sleep disturbances are themselves a risk factor for disease flare-ups. Thus, sleep and IBD may get caught in a dangerous feedback loop: poor sleep may worsen IBD, which in turn worsens sleep quality [R, R, R].
Crohn’s disease patients should do everything they can to regulate their sleep schedules, getting to bed at the same time every night and waking up at the same time each morning [R].
If you are having trouble with sleep, we recommend checking out our Sleep Wellness Report on SelfDecode.
A consistent sleep schedule is associated with healthy levels of autophagy, lower TNF-alpha, and less severe IBD symptoms.
Moderate Sun Exposure
Some researchers have identified vitamin D deficiency as a major risk factor for the development of IBD; they have furthermore suggested that it may regulate autophagy in inflammatory gut disorders, though this has not been directly studied in either humans or animals [R].
Vitamin D is believed to play a role both in supporting healthy autophagy and in reducing out-of-control autophagy under different circumstances [R].
In healthy adults, as vitamin D levels rise, TNF-alpha levels fall; people with vitamin D deficiency have much higher TNF-alpha and may be more susceptible to general inflammation [R].
Crohn’s disease (and the steroids used to treat it) have been linked to calcium and vitamin D deficiencies and subsequent osteoporosis. Your doctor will monitor your vulnerability to these deficiencies, and if appropriate, prescribe supplements. If vitamin D supplements are not recommended, the best way to make sure you’re getting enough is with moderate sun exposure [R, R, R].
Vitamin D appears to both stimulate and suppress autophagy depending on the circumstances, making it an extremely important nutrient for anyone with IRGM mutations. Moderate sun exposure is the best source of vitamin D.
Supplements
Green Tea
The major active compound in green tea is epigallocatechin gallate, or EGCG. EGCG stimulates autophagy and decreases TNF-alpha. Its effect on IRGM has not been studied, but because it increases autophagy, it likely increases IRGM as well. That would make it potentially more useful for people with IRGM variants that decrease expression [R, R].
EGCG from green tea is anti-inflammatory and is currently being studied for its potential benefits in Crohn’s disease. In animal models of Crohn’s, feeding EGCG supplements reduced the severity of symptoms and of tissue damage. There are no available clinical trials on EGCG in Crohn’s disease specifically, but the results of animal studies have been promising enough for many researchers to recommend moving forward with human studies [R, R].
EGCG from green tea stimulates autophagy and decreases TNF-alpha. In animal models of Crohn’s disease, it also improved symptoms and prevented tissue damage.
Eugenol
Eugenol is an anti-inflammatory plant polyphenol that inhibits both autophagy and TNF-alpha. Its precise effect on IRGM is unknown, but because of its strong effect on autophagy, some researchers have suggested a possible interaction. People with overexpression of IRGM may benefit most from eugenol [R, R, R].
A few studies have found that eugenol reduced the severity of damage to the gut wall, preventing the formation of ulcers. Eugenol has also shown some antidepressant properties, which may be helpful for Crohn’s disease patients with comorbid mental illness. However, other studies suggest that some people with IBD may be sensitive to eugenol [R, R].
Eugenol is found in many plants. The richest sources include cloves, cinnamon, and holy basil (tulsi), all of which are available as supplements or as tasty additions to your cooking [R].
Eugenol is among the only common plant polyphenols found to inhibit autophagy. If the other strategies on this list don’t work and you think you have IRGM overexpression, cloves and holy basil may be of interest.
Disclaimer
The information on this website has not been evaluated by the Food & Drug Administration or any other
official medical body. This information is presented for educational purposes only, and may not be used
to diagnose or treat any illness or disease.
Also keep in mind that the “Risk Score” presented in this post is based only on a select number of
SNPs, and therefore only represents a small portion of your total risk as an individual. Furthermore,
these analyses are based primarily on associational studies, which do not necessarily imply causation.
Finally, many other (non-genetic) factors can also play a significant role in the development of a
disease or health condition — therefore, carrying any of the risk-associated genotypes discussed in this
post does not necessarily mean you are at increased risk of developing a major health condition.
Always consult your doctor before acting on any information or recommendations discussed in this post —
especially if you are pregnant, nursing, taking medication, or have been officially diagnosed with a
medical condition.